We stratified cancer patients based on their OAS1 CNV levels and found that high OAS1 CNV levels were associated with shorter survival rates in COAD (HR=2.24, p = 0.001) and LUAD (HR=1.92, p=0.037) (Figure 5B). Here, OAS1 is linked to cancer.